undamentalytics Newsletter

Medtronic cash flow statement

In fiscal 2026, Medtronic's operations generated $7.33bn of cash; it spent $1.90bn on capital projects, leaving free cash flow of $5.43bn. It returned $3.64bn in dividends and $1.03bn through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Medtronic: cash flow statement, annual
Fiscal year2013Apr 20132014Apr 20142015Apr 20152016Apr 20162017Apr 20172018Apr 20182019Apr 20192020Apr 20202021Apr 20212022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026LTMJul 2026
Cash from operations4,9424,9594,9025,2186,8804,6847,0077,2346,2407,3466,0396,7877,0447,3308,035
Depreciation and amortisation8198501,3062,8202,9172,6442,6592,6632,7022,7072,6972,6472,8612,9582,035
Stock-based pay152145439375348344290297344359355393429457497
Capital spending4573965711,0461,2541,0681,1341,2131,3551,3681,4591,5871,8591,9041,903
Free cash flow4,4854,5634,3314,1725,6263,6165,8736,0214,8855,9784,5805,2005,1855,4266,132
Free cash flow after stock pay4,3334,4183,8923,7975,2783,2725,5835,7244,5415,6194,2254,8074,7564,9695,635
Dividends paid1,0551,1161,3372,1392,3762,4942,6932,8943,1203,3833,6163,6663,5893,6393,650
Share buybacks1,2472,5531,9202,8303,5442,1712,8771,3266522,5446452,1383,2351,0351,179
Shares issued2671,307649491428403992662474429308284508516441

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ABT vs MDTMDT vs SYKGEHC vs MDT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Medtronic's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medtronic.